X-linked agammaglobulinemia (XLA): A genetic tyrosine kinase (Btk) disease
(1996) In BioEssays 18(10). p.825-834- Abstract
- X-linked agammaglobulinemia is a heritable immunodeficiency disease caused by a differentiation abnormality, resulting in the virtual absence of B lymphocytes and plasma cells, The affected gene encodes a cytoplasmic protein tyrosine kinase, Bruton's agammaglobulinemia tyrosine kinase, designated Btk, Btk and the other family members, Tec, Itk and Bmx, contain five regions, four of which are common structural and functional modules that are found in other signaling proteins. Mutations affect all domains of the gene, but amino acid substitutions seem to be confined to certain regions, More than 150 unique mutations have been identified and are collected in a mutation database, BTKbase. Here we discuss the three-dimensional structural... (More)
- X-linked agammaglobulinemia is a heritable immunodeficiency disease caused by a differentiation abnormality, resulting in the virtual absence of B lymphocytes and plasma cells, The affected gene encodes a cytoplasmic protein tyrosine kinase, Bruton's agammaglobulinemia tyrosine kinase, designated Btk, Btk and the other family members, Tec, Itk and Bmx, contain five regions, four of which are common structural and functional modules that are found in other signaling proteins. Mutations affect all domains of the gene, but amino acid substitutions seem to be confined to certain regions, More than 150 unique mutations have been identified and are collected in a mutation database, BTKbase. Here we discuss the three-dimensional structural implications of such mutations and their putative functional role. Of special interest are mutations affecting the pleckstrin homology domain, as Btk is the only disease-associated protein so far reported to carry mutations in this particular module. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/3853058
- author
- Mattsson, PT ; Vihinen, Mauno LU and Smith, CIE
- publishing date
- 1996
- type
- Contribution to journal
- publication status
- published
- subject
- in
- BioEssays
- volume
- 18
- issue
- 10
- pages
- 825 - 834
- publisher
- John Wiley & Sons Inc.
- external identifiers
-
- wos:A1996VN99400008
- scopus:0030272507
- ISSN
- 0265-9247
- DOI
- 10.1002/bies.950181009
- language
- English
- LU publication?
- no
- id
- 4fc46b03-972b-4e6e-8e0e-9d894cf060d4 (old id 3853058)
- date added to LUP
- 2016-04-01 12:02:25
- date last changed
- 2022-03-13 04:22:56
@article{4fc46b03-972b-4e6e-8e0e-9d894cf060d4, abstract = {{X-linked agammaglobulinemia is a heritable immunodeficiency disease caused by a differentiation abnormality, resulting in the virtual absence of B lymphocytes and plasma cells, The affected gene encodes a cytoplasmic protein tyrosine kinase, Bruton's agammaglobulinemia tyrosine kinase, designated Btk, Btk and the other family members, Tec, Itk and Bmx, contain five regions, four of which are common structural and functional modules that are found in other signaling proteins. Mutations affect all domains of the gene, but amino acid substitutions seem to be confined to certain regions, More than 150 unique mutations have been identified and are collected in a mutation database, BTKbase. Here we discuss the three-dimensional structural implications of such mutations and their putative functional role. Of special interest are mutations affecting the pleckstrin homology domain, as Btk is the only disease-associated protein so far reported to carry mutations in this particular module.}}, author = {{Mattsson, PT and Vihinen, Mauno and Smith, CIE}}, issn = {{0265-9247}}, language = {{eng}}, number = {{10}}, pages = {{825--834}}, publisher = {{John Wiley & Sons Inc.}}, series = {{BioEssays}}, title = {{X-linked agammaglobulinemia (XLA): A genetic tyrosine kinase (Btk) disease}}, url = {{http://dx.doi.org/10.1002/bies.950181009}}, doi = {{10.1002/bies.950181009}}, volume = {{18}}, year = {{1996}}, }